ESC Premium Access

Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Congress Presentation

About the speaker

Doctor Sheila Hegde

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
1 presentation
0 follower

7 more presentations in this session

Effect of Aficamten on Cardiac Structure and Function in Patients with Obstructive Hypertrophic Cardiomyopathy: The SEQUOIA-HCM CMR Trial

Speaker: Doctor A. Masri (Portland, US)

Thumbnail

Effect of Aficamten on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM

Speaker: Doctor J. Spertus (Kansas City, US)

Thumbnail

Safety and Outcomes of Standard of Care Medications Withdrawal in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Aficamten in FOREST-HCM Trial

Speaker: Doctor A. Masri (Portland, US)

Thumbnail

Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis

Speaker: Associate Professor M. Banovic (Belgrade, RS)

Thumbnail

Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: A subanalysis from the DEDICATE-DZHK6 trial

Speaker: Professor S. Bleiziffer (Bad Oeynhausen, DE)

Thumbnail

Access the full session

Trial updates and other studies in hypertrophic cardiomyopathy and aortic stenosis

Speakers: Doctor S. Hegde, Doctor A. Masri, Doctor J. Spertus, Doctor A. Masri, Associate Professor M. Banovic...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations